Alliance of Glycobiologists

Meetings and Events

6th Steering Committee Meeting
October 1, 2012
University of Texas, San Antonio, San Antonio, TX

Initial planning meeting of the newly funded teams for the second installment of the Alliance. Coincided with the 25th Steering Committee Meeting of the Early Detection Research Network


Glycoscience Symposium Hosted by the Alliance of Glycobiologists for Detection of Cancer and Cancer Risk
January 24, 2012
Natcher Conference Center
National Institutes of Health
Bethesda, MD

Interfacing Glycoscience with Disease and Clinical Practice

Over the last two decades, we have seen revolutionary developments in genomics and proteomics. While these advances have had a profound impact on our understanding of diseases and the approaches used to treat them, they often overlook the role of glycans. These molecular structures are found mainly on cell surfaces and within the intercellular matrix where many disease processes are mediated. Glycans also represent the largest class of posttranslational modification of proteins and frequently modulate protein function.

The objectives of this symposium are to highlight key developments in glycoscience and how these are proving beneficial in advancing medicine. This symposium will emphasize the diversity of roles glycans and their binding proteins play in a plethora of fundamental biological processes. Specific attention will be given to compelling examples in disease treatment and prevention, such as inflammation, tissue regeneration, viral pathogenesis, neuronal integrity, and cancer.


Fifth Coordination Unit Meeting
February 17, 2011
San Diego, CA

Coincided with the 14th Annual San Diego Glycobiology Symposium Exit Disclaimer


Integrating Glycomics with other Omics in Cancer Detection and Diagnosis
January 19-20, 2010
Menlo Park, CA

The first day of this workshop Exit Disclaimer featured a number of distinguished scientists providing explicit examples of how glycobiology impinges on a diverse aspects of cancer biology. Presentations by all Alliance PIs consitituted the afternoon session of the first day. During the second day a closed session was held where invited speakers met with the Alliance and NIH program staff to discuss prospective upcoming directions for the future of the Alliance.


Fourth Coordination Unit Meeting, Preparation for Renewal
September 2-3, 2009
Bethesda, MD

Key presentations focused on goals and deliverables of the program, and lessons learned in diagnostic research.


Third Coordination Unit Meeting
March 27, 2009
Ise-Shima, Mie, Japan

Clinical and Translational Research on Cancer: Glycomics Applications
March 24-27, 2009
Ise-Shima, Mie, Japan

The meeting included special presentations by young investigators and many renowned glycobiologists from Japan, Korea, the U.S. and Europe. Sponsored by: NCI; Human Disease Glycomics/Proteomics Initiative under the Human Proteome Organization; Japan Society for the Promotion of Science; New Energy and Industrial Technology Development Organization; Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; National Institute of Advanced Industrial Science and Technology; Global COE program, Osaka University; and the Mizutani Foundation for Glycoscience.


Second Coordination Unit Meeting
March 16, 2008
Bethesda, MD

Sponsored in connection with the Division of Cancer Prevention Early Detection Research Network.


Initial Planning Meeting to Launch the Alliance
August 13-14, 2007
Rockville, MD

Topics included: components of the Alliance, research focus, and crafting the Manual of Operations.

Back to top

Coming Up

May 4, 2017
Alliance Steering Committee meeting
Natcher Building
NIH Campus
Bethesda, MD

Last updated: 28 February 2017